New Drug Combats Multidrug Resistant Tuberculosis


    loading  Checking for direct PDF access through Ovid

Abstract

Bedaquiline (Sirturo) is a new drug to treat multidrug-resistant pulmonary tuberculosis. It is administered as part of multidrug therapy when other antitubercular therapy cannot be used.Bedaquiline increases the risk of death and can prolong the QT interval, producing serious ventricular arrhythmias.

    loading  Loading Related Articles